2025
A Relook at the Relevance of Thyroid Stimulating Hormone and Thyroid Autoimmunity for Pregnancy Outcomes: Analyses of Randomized Control Trials Data From Pregnancy and Polycystic Ovary Syndrome and Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
Kuokkanen S, Seungdamrong A, Santoro N, Lieman H, Sun F, Wild R, Zhang H, Pal L. A Relook at the Relevance of Thyroid Stimulating Hormone and Thyroid Autoimmunity for Pregnancy Outcomes: Analyses of Randomized Control Trials Data From Pregnancy and Polycystic Ovary Syndrome and Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation. Obstetrical & Gynecological Survey 2025, 80: 561-562. DOI: 10.1097/ogx.0000000000001445.Peer-Reviewed Original ResearchPreterm deliveryThyroid autoimmunityAssessment of Multiple Intrauterine GestationsAssociated with pregnancy complicationsLow birth weightThyroid-stimulating hormonePolycystic ovary syndromeIntrauterine gestationPregnancy complicationsPregnancy outcomesOvarian stimulationBirth weightStimulating hormonePregnancy lossPregnancyAssociated with negative outcomesPretermHypothyroidismAutoimmunityThyroidTrial dataOutcomesDeliveryGestationComplications
2024
A relook at the relevance of thyroid stimulating hormone and thyroid autoimmunity for pregnancy outcomes: Analyses of randomized control trials data from Pregnancy in Polycystic Ovary Syndrome and Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation
Kuokkanen S, Seungdamrong A, Santoro N, Lieman H, Sun F, Wild R, Zhang H, Pal L. A relook at the relevance of thyroid stimulating hormone and thyroid autoimmunity for pregnancy outcomes: Analyses of randomized control trials data from Pregnancy in Polycystic Ovary Syndrome and Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation. Fertility And Sterility 2024, 123: 873-882. PMID: 39672366, PMCID: PMC12045735, DOI: 10.1016/j.fertnstert.2024.12.005.Peer-Reviewed Original ResearchThyroid-stimulating hormoneRandomized Controlled TrialsTPO-AbThyroid autoimmunityPregnancy outcomesAssessment of Multiple Intrauterine GestationsRetrospective cohort analysis of dataRisk of pregnancy lossEarly preterm birthMaternal TSH levelsThyroid peroxidase antibodyCohort analysis of dataRetrospective cohort analysisBody mass indexDuration of infertilityAnalysis of RCT dataPolycystic ovary syndromeIntrauterine gestationPreterm birthTSH levelsPeroxidase antibodiesOvarian stimulationLive birthsPPCOS IIStimulating hormone
2017
Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women
Seungdamrong A, Steiner AZ, Gracia CR, Legro RS, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Robinson RD, Huang H, Alvero R, Hansen KR, Jin S, Eisenberg E, Zhang H, Santoro N, Network E. Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women. Fertility And Sterility 2017, 108: 843-850. PMID: 29102040, PMCID: PMC8129952, DOI: 10.1016/j.fertnstert.2017.08.026.Peer-Reviewed Original ResearchAnti-TPO antibodiesLive birth rateThyroid-stimulating hormoneAntithyroid peroxidase antibodiesMIU/LInfertile womenClinical pregnancyPeroxidase antibodiesLive birthsReproductive outcomesBirth rateEunice Kennedy Shriver National InstituteMultivariable logistic regression analysisMultivariable logistic regression modelReproductive Medicine NetworkMIU/L.Adverse reproductive outcomesHigher miscarriage ratePoor reproductive outcomesRisk of miscarriageLogistic regression analysisLogistic regression modelsSimilar conception ratesMiscarriage rateTSH levels
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply